|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
This excerpt taken from the LUX 20-F filed Jun 25, 2009. Benefit Payments The
following estimated future benefit payments for the health benefit plans, which
reflect expected future service, are estimated to be paid in the years
indicated (thousands of Euros):
This excerpt taken from the LUX 6-K filed May 12, 2009. Benefit payments. The following estimated future benefit
payments for the health benefit plans, which reflect expected future service,
are estimated to be paid in the years indicated (thousands of Euro):
This excerpt taken from the LUX 20-F filed Jun 26, 2008. Benefit Payments The following estimated
future benefit payments for the health benefit plans, which reflect expected
future service, are estimated to be paid in the years indicated for both the
Holdings and Cole plans (thousands of Euro),
Contributions The expected contributions for 2008 are Euro 0.2 million for the Company and Euro 0.1 million for the employee participants.
For 2007, a 11.5% (12% for 2006) increase in the cost of covered health care benefits was assumed. This rate was assumed to decrease gradually to 5% for 2020 and remain at that level thereafter. The health care cost trend rate assumption could have a significant effect on the amounts reported. A 1% increase or decrease in the health care trend rate would not have a material impact on the consolidated financial statements. The weighted-average discount rate used in determining the accumulated postretirement benefit obligation was 6.5% at September 30, 2007 and 6.0% at September 30, 2006.
The weighted average discount rate used in determining the net periodic benefit cost was 6.0% for 2007 and 5.75% for 2006.
F-37
This excerpt taken from the LUX 6-K filed Jun 4, 2008. Benefit payments. The following
estimated future benefit payments for the health benefit plans, which reflect
expected future service, are estimated to be paid in the years indicated for
both the Holdings and Cole plans.
This excerpt taken from the LUX 20-F filed Jun 29, 2007. Benefit PaymentsThe following estimated future benefit payments for
the health benefit plans, which reflect expected future service, are estimated
to be paid in the years indicated for both the Company and Cole plans (amounts
in thousands of Euro):
This excerpt taken from the LUX 6-K filed May 25, 2007. Benefit
payments - The following estimated future benefit payments,
which reflect expected future service, are expected to be paid in the years
indicated for both the US Holdings and Cole plans:
This excerpt taken from the LUX 20-F filed Jun 28, 2006. Benefit PaymentsThe following estimated future benefit payments,
which reflect expected future service, are estimated to be paid in the years
indicated for both the US Holdings and Cole plans (amounts in thousands of Euro
translated for convenience at the noon buying rate at December 31, 2005):
ContributionsThe expected contributions for 2005 are Euro 0.2 million for the Company and Euro 0.1 million for the employee participants. For 2005, a 10.0 percent (10.5 percent for 2004) increase in the cost of covered health care benefits was assumed. This rate was assumed to decrease gradually to 5 percent for 2015 and remain at that level thereafter. The health care cost trend rate assumption has a significant effect on the amounts reported. A 1.0 percent increase or decrease in the health care trend rate would have an immaterial impact on the consolidated financial statements. The weighted-average discount rate used in determining the accumulated post-retirement benefit obligation was 5.75 percent at September 30, 2004 and 6.00 percent at September 30, 2005. The weighted-average discount rate used in determining the net periodic benefit cost for 2004 and 2005 was 5.75 percent and 6.0 percent, respectively. Certain of the Companys non-Italian and non-US subsidiaries provide limited non-pension benefits to retirees in addition to government sponsored programs. The cost of these programs is not significant to the Company. On December 8, 2003, the Medicare Prescription Drug Improvement and Modernization Act of 2003 (the Act) was signed into law. In accordance with FASB Staff Position 106-2, the Companys measures of accumulated postretirement benefit obligation and net periodic benefit cost in the consolidated financial statements reflect the effects of the Act. The adoption of FASB Staff Position 106-2 did not have a material effect on the Companys consolidated financial statements. This excerpt taken from the LUX 20-F filed Jun 29, 2005. Benefit PaymentsThe
following estimated future benefit payments, which reflect expected future
service, are expected to be paid in the years indicated for both the Luxottica
and Cole plans (translated for convenience at the December 31, 2004 noon
buying rate):
| EXCERPTS ON THIS PAGE:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||